Press

High-Tech Gründerfonds has successfully sold its shares in textunes GmbH. With the purchase of textunes GmbH, Thalia is acquiring one of the leading providers of eBooks and eBook apps. With this step Thalia is setting new standards in digital reading as part of its "Smart Reading Strategy". textunes was founded in 2009 by the three eBook enthusiasts Simon Seeger, Michael Oesterreich and Volker Oppmann as well as theCo.de AG. With financial support from High-Tech Gründerfonds the start-up ha

Automotive supplier Marquardt, High-Tech Gründerfonds and Bayern Kapital strengthen their ties with baimos technologies, a leader in the field of mobile security solutions. BlueID technology, a system for secure digital identification by mobile phone, meets growing interest in the automotive sector. BlueID Drive is a development of baimos technologies and automotive supplier Marquardt. It provides the possibility to send access permissions and driver authorizations to mobile phones. In turn, c

Lophius Biosciences, a leading developer of novel, innovative T-cell-based diagnostic test systems, announced today closing  of an additional financing round totaling 1.4 million EUR. All current financial investors, such as S-Refit, High-Tech Gründerfonds (HTGF) as well as Bayernkapital participated in this financing round. The funds will be used for the market introduction of the T-Track© CMV/EBV tests in the field of transplantation, for further development of a diagnostic test for the dif

Unique business model, technical know-how and comprehensive expertise convince investors. crealytics GmbH attracts new investors: In addition to early stage investors Bayern Kapital, the Passau-based profit driven search marketing specialists have received a fresh injection of capital from LBBW Venture Capital GmbH and Mountain Super Angel AG. LBBW Venture Capital GmbH and Mountain Super Angel AG will support the young, innovative technology business as lead investors. crealytics GmbH is

Tengelmann and previous investors have invested in deal united to push ahead the expansion of the Munich-based payment specialist. deal united, provider of the innovative payment method PAY.BY.SHOPPING, has successfully concluded a second round of financing. In addition to the lead investor Tengelmann E-Commerce Beteiligungs GmbH, the existing investors Bertelsmann Digital Media Investments in corporation with KFW Bankengruppe, High-Tech Gründerfonds and Venture Incubator have also joined th

famPlus GmbH has successfully completed a first round of financing. High-Tech Gründerfonds (HTGF), Bayern Kapital and a ‘business angel’ consortium will be supporting the family services company in future. Prior market success convinced investors. The fresh infusion of capital is intended to accelerate growth and product development in the coming months. “We are very happy to now have experienced investors and experts on board,” says Dr. Markus Solf, Managing Director and founder of

Berlin-based Software-as-a-Service company Krauttools GmbH was able to convince with its customer feedback platform, “reqorder” and is bringing High-Tech Gründerfonds (HTGF) on board as an investor. Krauttools GmbH develops and markets the “reqorder” customer feedback platform and is the first German provider serving this growth market with a data protection compliant solution. “reqorder” offers self-service or app-economy companies the possibility of polling customer views and t

Cologne-based medical technology company NonWoTecc Medical GmbH is receiving growth financing from NRW.BANK as well as from an industry-experienced consortium of private investors headed by Rainer Christine. Previous investors Rheinland Venture Capital, Kreissparkasse Köln, High-Tech Gründerfonds and KfW are also participating in the second financing round. The fresh capital of €7 m is to be used for the product approval and launch of vascular prostheses in the peripheral and coronary areas

Creathor Venture and current investors invest in SIRION BIOTECH and provide further funding. In addition to Creathor Venture the investors High-Tech-Gründerfonds, KfW, and Bayernkapital also joined the current round to further fund the young Munich based biotech. SIRION’s core competence lies in the development and marketing of adenoviral and lentiviral vector technologies in the field of target validation. A part of the new proceeds will be used to further promote already developed tec

Dallas and Berlin-based Dental Technology Company Receives 1M EUR from BB Biotech Ventures and IBB Beteiligungsgesellschaft Natural Dental Implants (NDI), Inc. the Dallas-based subsidiary of Natural Dental Implants AG, headquartered in Berlin, Germany, today announced the closing of a follow-on financing of 1,000,000 EUR to be used for commercializing the Company’s patented REPLICATE™ Non-surgical Tooth Replacement System.  A new investor to the Company, BB Biotech Ventures, advised by the

The company Compositence GmbH is set to play a major role in providing broader applications for carbon-fibre components. This promises to not only benefit the environment but also to enable sustainable company growth. Joint financing through High-Tech Gründerfonds and the Seedfonds Baden-Württemberg represents a further step towards industrial applications for the innovative engineered products company. The company's innovative concept is a process technology for processing carbon fibres. T

m2p-labs reaches break-even point and strengthens growth with new capital m2p-labs reaches break-even point, thanks to a strong demand for technology in 2010. Strengthened by good sales figures, long-standing investors are now investing in the company’s growth: the Seed Fund for the Region of Aachen GmbH & Co. KG, the KfW with the ERP Start-Up Fund and the High-Tech-Gründerfonds (business start-up fund), as well as two private investors. m2p-labs is a leading provider of innovative scr

JobLeads met its profitability threshold at the end of 2010, prompting investors and management to provide the company with additional growth equity: around one million euros will be invested in marketing and B2C activities, an area in which the company has successfully expanded recently. The investors High-Tech Gründerfonds, Michael W. Schwetje, Andreas Hanitsch and Jan Andresen, together with the company management, provided the firm with around one million euros as part of a further fina

German Biotech MYR GmbH develops the viral entry inhibitor Myrcludex, a so-called „first-in-class“ drug for the treatment of chronic hepatitis B and D infections. The HTGF investment of 500,000 € enables the start of Phase 1 of clinical development already in summer 2011. MYR develops its lead compound in close collaboration with the University Clinic Heidelberg, one of the world-leading centers for biomedical research. The pre-clinical studies have been successfully completed. Myrclude

windeln.de, Germany's largest online web store for baby products, successfully completed its Series A financing. Led by the British venture capital company DN Capital, the High-Tech Gründerfonds (HTGF) and a consortium of existing shareholders invested again in the company's growth. The Munich-based growth equity investor Acton Capital Partners could be gained as a new investor in this round. windeln.de was founded in 2010 by Konstantin Urban, Alexander Brand and Dagmar Mahnel and has been o

Erlangen-based start-up “Lumatix” brings investors High-Tech Gründerfonds (HTGF) and Bayern Kapital on board. The approx. €600,000 in financing is intended mainly to finance further development and market entry. Lumatix has developed a high-tech software solution that simulates how natural light behaves in the real world. What makes it special is that the Lumatix software takes only a few milliseconds (instead of minutes or hours as in the past) to perform a the light simulation and to